| 23/271 |
Sleep Apnoea & CPAP Devices |
| 23/269 |
Virtual Wards |
| 23/267 |
Agencies |
| 23/266 |
Psychiatric Inpatient Wards |
| 23/265 |
Estates and Procurement Contacts |
| 23/259 |
Sexual Harassment in the NHS |
| 23/258 |
Admissions & Discharges |
| 23/257 |
Agency Staff |
| 23/253 |
Strategy Committee Summary, 23rd February 2023 |
| 23/250 |
Remote Working |
| 23/249 |
Dermatological Conditions |
| 23/248 |
Electronic Patient Record (EPR) |
| 23/247 |
Biologic and Targeted Medications within Dermatology and Respiratory Medicine |
| 23/245 |
Annual Reports & Financial Statements |
| 23/244 |
Immunoglobulin Drugs |
| 23/243 |
Medicines |
| 23/242 |
Clotting Disorders |
| 23/241 |
Assaults on Staff |
| 23/240 |
Guidelines for Idiopathic Pulmonary Fibrosis |
| 23/239 |
Active Transport |
